Ambulatory Care Conference

Similar documents
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Maria Angela S. Cruz-Anacleto, MD

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia

ijcrr A DIFFUSE CORONARY SPASM A VARIANT OF A VARIANT?

12 Lead EKG Chapter 4 Worksheet

Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room

Who Needs Admission and Who can go home?

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Cho et al., 2009 Journal of Cardiology (2009), 54:

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

Ischemic Heart Diseases. Dr. Nabila Hamdi MD, PhD

63 yo woman with chest pain

BIOAUTOMATION, 2009, 13 (4), 89-96

Pathophysiology of Coronary Microvascular Dysfunction

Results of Ischemic Heart Disease

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Microvascular Disease: How to Diagnose and What s its Treatment

Non-Invasive Evaluation of Coronary Vasospasm Using a Combined Hyperventilation and Cold-Pressure-Test Perfusion CMR Protocol

Patients with cardiac syndrome

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Introduction to Risk Stratification

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

Women and Vascular Disease

Women and Heart Disease

Approach to patient with hypertension. Dr. Amitesh Aggarwal

Takotsubo Cardiomyopathy: Pathophysiology and Assessment

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Treatment of T Angina reatment of By Ali Alalawi

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Ischemic Heart Disease

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Kintur Sanghvi Cezar Staniloae Sudhesh Srivastava John Coppola. Journal of Invasive Cardiology April 2006 ISSN: Volume 18 - Issue 4

Non ST Elevation-ACS. Michael W. Cammarata, MD

Angina Pectoris Dr. Shariq Syed

Difficult to Treat Hypertension

ACUTE CORONARY SYNDROME

Patient Management Code Blue in the CT Suite

Sleep and the Heart. Sleep Stages. Sleep and the Heart: non REM 8/31/2016

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Acetylcholine coronary spasm provocation testing: Revaluation in the real clinical practice

Risk Stratification for CAD for the Primary Care Provider

Amelia Carro Hevia MD and JC Kaski, MD DSc DM (Hons) FESC FACC FRCP Cardiovascular Sciences Research Centre St George s, University of London

Categories of HTN. Overview of Hypertension. Types of Hypertension

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

The use of Cardiac CT and MRI in Clinical Practice

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

The Effect of Sleep Disordered Breathing on Cardiovascular Disease

2018 HPN Provider Summary Guide. Adult Cardiology Patients (18 Years and Older) Referral Guidelines

Cardiac Pathophysiology

Cardiogenic Shock. Carlos Cafri,, MD

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Coronary Artery Disease & Acute Coronary Syndrome

Ischemic heart disease

Unit 4 Problems of Cardiac Output and Tissue Perfusion

Nitroglycerin and Heparin Drip Interfacility Protocols

Stress echo workshop STRESSORS

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Management of Postoperative Atrial Fibrillation

Recommended Evaluation Data Excerpt from NVIC 04-08

9/2/2016 CARDIOLOGY TESTING WHAT TO ORDER WHEN REFERENCE OBJECTIVES

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

LAB 4: THE MUSCLE AND CARDIOVASCULAR SYSTEM THE MUSCLE AND CARDIOVASCULAR SYSTEM

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

HEART CONDITIONS IN SPORT

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Consensus document: Screening and Prevention of Atrial Fibrillation

Angina Luis Tulloch, MD 03/27/2012

A Cardiologist s Guide to Love

Heart Failure (HF) Treatment

Acute coronary syndromes

Recent Treatment of Pulmonary Artery Hypertension. Cardiology Division Yonsei University College of Medicine

Heart Failure Background, recognition, diagnosis and management

Heart Failure A Team Approach Background, recognition, diagnosis and management

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Pre Hospital and Initial Management of Acute Coronary Syndrome

Chest Pain. Dr. Amitesh Aggarwal. Department of Medicine

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Drug Profiles Professional Responder

Hypertension and Atrial Fibrillation in 2017

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Cardiology. Final Written Examination 2019

CCRN Review Cardiovascular

Carotid Revascularization

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Hypertension Management Controversies in the Elderly Patient

E.C.G. QUIZ. Case History

Educational Goals and Objectives for Rotations on: Cardio Inpatient

Advanced Care for Decompensated Heart Failure

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Transcription:

Ambulatory Care Conference David Stultz, MD August 28, 2002

Case Presentation 50 year old white female presents to ED with substernal chest pain. Pain started while driving, is left substernal in location like an elephant sitting on my chest. She has radiation to the left arm and a tightness in her neck. She rates the pain a 9/10. The pain has now been going on over an hour.

Past Medical History Sleep apnea x 2 years, on CPAP Hypertension x 1 year Family history significant for DM, CHF

Physical Exam T 97 4 BP 122/72 P 67 R 20 General: Obese WF in acute distress Neck: No JVD or bruits Heart: RRR with 2/6 SEM RUSB Lungs: CTA B Abdomen: Benign Extremities: No C/C/E, good pulses

Therapeutics ASA 325 mg po given Placed on 2L O 2 nasal cannula SL nitroglycerin attempted x 2 without change in chest pain GI Cocktail administered no response

Laboratory Data CBC normal Electrolytes normal Chest Xray normal EKG NSR with <1mm lateral ST segment depression with flattening of t waves First Cardiac Enzymes negative

Hospital Course Attempted GXT-Thalium 7 minutes, 1-2 mm ST down sloping in inferolateral leads (+) with associated chest pain Small persistent anterior wall perfusion abnormality EF 59% at rest 70% with exercise Started on heparin IV (CAD protocol) Admitted to telemetry Pain resolved spontaneously No further recurrence Cardiac Enzymes all negative

Next morning Followup EKG demonstrated similar lateral ST segment changes Cardiac Catheterization Normal LV function Normal coronary vasculature Acetylcholine challenge negative Discharged from hospital with diagnosis of non cardiac chest pain and instructed to followup with primary care in 1-2 weeks.

Subsequently Patient continued to experience similar episodes of chest pain about 1-2 times per day. Each episode had similar pattern Nonexertional Anginal quality Lasted around 1 hour Spontaneous resolution Ultimately went on disability due to pains

Differential Diagnosis of chest pain with a normal angiogram Anxiety Esophageal spasm GERD Prinzmetal s Angina (epicardial coronary vasospasm) Systemic Hypertension Left Ventricular Hypertrophy Valvular Heart Disease

Cardiac Syndrome X Described by H.G. Kemp in editorial Etymology 1973 Study by R. Arbogast and M. G. Bourassa Grouped patients with chest pain into 2 groups: Patients with CAD Patients without angiographic evidence of CAD Compared EKG and hemodynamic response to atrial pacing during cardiac catherization

Etymology Study found that patients with normal coronary arteries (Group X) had normal left ventricular function despite having typical ischemic EKG changes Group X arbitrarily named as such

Cardiac Syndrome X is not Metabolic Syndrome [X] Metabolic Syndrome [X] Truncal Obesity Hypertriglyceridemia Hypertension Diabetes mellitus type 2 Implicated with coronary artery disease

A Clinical Definition Angina Positive stress test Normal coronary angiogram About 10-20% of patients with chest pain Exclusions Vasospasm, Hypertension Extracardiac sources of pain

Chest Pain Similar in character and radiation to angina Occurs at rest (41%) Long lasting (10 minutes to hours) Relieved by nitroglycerin about 50% Pain does not cause LV dysfunction!

EKG Changes Stress testing 20% with abnormal stress tests Many patients unable to complete test due to pain EKG changes similar to patients with ischemic disease Changes appear at higher HR-BP product Holter monitoring circadian distribution similar to ischemic disease ST segment depression much more common than elevation ST segment changes last longer than those with angina

Stress Testing Normal Baseline ST Segment depressions at peak exercise Positive Test ST depression persists longer than expected

Ambulatory Monitoring

Left Ventricular Function Normal LV function with episodes of pain and ST segment changes Contrast to ischemic disease which does show decreased LV function

Theories of Syndrome X Ischemic vs. Abnormal Pain Perception (or a combination) Microvascular Dysfunction Estrogen Deficiency Abnormal Pain Perception Enhanced activity of Sodium-Lithium Countertransport pump Autonomic Dysregulation

Myocardial Perfusion 30% of Syndrome X show transient abnormalities Relative differences in myocardial perfusion Perfusion is heterogeneous in Syndrome X New studies indicate ischemic source of abnormalities

Microvascular Dysfunction 1981 Opherk showed myocardial lactate production during atrial pacing in some patients with syndrome X Decreased endothelial response to vasodilatory signals Nitric Oxide Increased Endothelin (vasoconstrictor)

Pathogenesis of Endothelial Dysfunction Conventional CAD risks Smoking Hyperlipidemia Estrogen deficiency Insulin resistance

Estrogen Deficiency Most patients with Syndrome X are peri or post-menopausal women Acute administration of transdermal estradiol improves coronary vasodilation Two months of estrogen replacement maintained vasodilator response

Abnormal Pain Perception Adenosine infusion results in more pain in syndrome X patients than those with CAD Intracardiac catheter manipulation produced typical chest pain without evidence of blood flow abnormality

Sodium-Lithium Countertransport Insulin resistance causes enhanced activity of sodium-lithium countertransport pump Responsible for maintaining intracellular calcium concentrations High intracellular calcium leads to increased coronary microvascular tone High tone may lead to perfusion deficits

Autonomic System Increased sympathetic drive Increased response of coronary arteries to sympathetic stimulation

Prognosis 96% 7-year survival rate 1/3 of deaths cardiovascular in origin Hypertension and Smoking predicted mortality Stress test response did not affect mortality Pain may cause severe morbidity Conflicting data on progression of Left Ventricular dysfunction Few patients show progression to CAD on second angiogram

Treatment Goals Control Pain Improve Function No one standard therapy Often must be individualized

Cardiac Medications Calcium channel blockers Diltiazem widely used Nitrates Beneficial in 40-50% of Syndrome X patients β-blockers Useful for patients with increased sympathetic activity ACE inhibitors? Possible renin-angiotensin activity in Syndrome X?

Other Medications Tricyclic antidepressants Imipramine Amitriptyline Aminophylline Blocks adenosine purinergic receptors Estrogen Transdermal 17-β estradiol

Multidisciplinary Treatment Psychological Assessment Control risks for endothelial dysfunction Smoking Hyperlipidemia Estrogen deficiency Insulin resistance Trial and error treatment Pain recurrences

Case Presentation Patient started on Elavil 25 mg qhs Atenolol 50 mg qd Estrogen/progestin No further episodes of chest pain Returned to work in 2 weeks Attempts to withdraw medications once a year each time has recurrence of chest pain Recently stopped estrogen/progestin without exacerbation Recent GXT-thalium negative

Bibliography Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002 Jun 20;346(25):1948-53. Braunwald E, Zipes DP, Libby P. Heart Disease 6 th ed. 1328-1330. Cardiac syndrome X: an overview. Hosp Pract. 2000 Feb 15;35(2):75-88.